NYXH — Nyxoah SA
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1857190 ·
Belgium
Last close
$1.45
Market Cap
$147.67M
52W High
$6.88
52W Low
$1.26
ADV30
415,247
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,675,000 | 4,584,000 | -20,548,000 | -32,964,000 | 168,466,000 | 64,115,000 | 85,357,000 |
| Mar 2026 | 6,372,000 | 3,638,000 | -20,503,000 | -15,944,000 | 97,598,000 | 12,934,000 | 61,727,000 |
| Dec 2025 | 5,644,000 | 3,625,000 | -18,259,000 | -23,513,000 | 118,471,000 | 30,001,000 | 69,342,000 |
| Sep 2025 | 1,972,000 | 1,193,000 | -24,195,000 | -23,580,000 | 93,599,000 | 10,869,000 | 42,645,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-71,855,000
Investing CF
$-16,154,000
Financing CF
$128,292,000
CapEx
$-3,621,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.16
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-353,570,000
Inventory
$3,706,000
Receivables
$9,953,000
ST Investments
$33,670,000
EBIT TTM
$-83,376,000
Pretax Income TTM
$-94,529,000
Interest Exp TTM
$11,153,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,663,000
EBITDA
$-82,744,000
Free Cash Flow
$-46,059,124
Enterprise Value
$116,315,136
Total Cash
$97,785,000
Total Debt
$59,988,000
Shares Out
101,840,217
Trailing EPS
$-2.55
Book Value
$0.97
ROE
-122.7%
ROA
-36.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,020,000 | -82,942,000 | -90,085,000 | 118,471,000 | 69,342,000 | 49,129,000 | -68,979,000 |
| Dec 2024 | 4,521,000 | -58,809,000 | -59,236,000 | 158,406,000 | 45,152,000 | 113,254,000 | -49,226,000 |
| Dec 2023 | 4,348,000 | -45,102,000 | -43,212,000 | 124,157,000 | 26,135,000 | 98,022,000 | -44,778,000 |
| Dec 2022 | 3,084,000 | -32,499,000 | -31,225,000 | 146,071,000 | 25,747,000 | 120,324,000 | -28,756,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.85
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KRMD | KORU Medical Systems, Inc. | $147.44M | $3.21 | — |
| INGN | Inogen Inc | $142.25M | $5.36 | — |
| ZJYL | Jin Medical International Ltd. | $140.70M | $1.91 | — |
| LUCD | Lucid Diagnostics Inc. | $157.72M | $0.83 | — |
| STXS | Stereotaxis, Inc. | $130.26M | $1.30 | — |
News headlines (Yahoo Finance, 1h cache)
Nyxoah Announces Chief Financial Officer Transition
2026-09-21 20:01 · Yahoo
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
2026-09-10 21:18 · Yahoo
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
2026-09-08 15:17 · Yahoo
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
2026-09-07 20:05 · Yahoo
Nyxoah Shares Jump After Genio Meets Primary Endpoints in CCC Patient Study
2026-09-02 21:48 · Yahoo
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
2026-09-02 20:05 · Yahoo
Dr. Andrew Patel and Oath Surgical Bring Sleep Apnea Implant to Oregon in a First for Pacific Northwest Outpatient Surgery
2026-08-26 15:00 · Yahoo
CVRx names John Landry as CFO
2026-09-23 14:00 · Yahoo
CVRx Appoints John Landry as Chief Financial Officer
2026-09-21 20:07 · Yahoo
Information on the total number of voting rights and shares
2026-08-25 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.